Skip to content

Legend Biotech

US · LEGN #2374 by market cap Listed 2020
15.25 -0.85 -5.28%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
D-
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Deteriorating
4
■ Upgrades■ Downgrades
  • 0 upgrades vs 4 downgrades among tracked analyst rating changes.
  • Most recent: Oppenheimer moved from Buy to Hold on 2026-08-12.

Analyst consensus 10 analysts

Buy
Avg price target 41.90 +174.8%
Price target rangecurrent 15.25
Low20.00
Avg41.90
High65.00
Buy 60% Hold 40% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 Evercore -- Hold 20.00
2026-11-11 Morgan Stanley -- Buy 43.00
2026-11-11 Goldman Sachs -- Buy 34.01
2026-11-11 H.C. Wainwright -- Buy 65.00
2026-11-11 Barclays -- Buy 61.00
2026-11-11 Oppenheimer -- Hold 25.00
2026-11-10 RBC Capital -- Buy 50.00
2026-11-06 Barclays -- Buy 68.00
2026-11-05 Piper Sandler -- Buy 64.00
2026-11-05 H.C. Wainwright -- Buy 65.00
2026-11-05 RBC Capital -- Buy 56.00
2026-10-30 H.C. Wainwright -- Buy 65.00
2026-10-29 H.C. Wainwright -- Buy 65.00
2026-10-27 UBS -- Hold 24.00
2026-10-19 H.C. Wainwright -- Buy 65.00
2026-10-15 H.C. Wainwright -- Buy 65.00
2026-10-14 Goldman Sachs -- Buy 38.09
2026-10-14 H.C. Wainwright -- Buy 65.00
2026-10-13 Barclays -- Buy 68.00
2026-10-09 J.P. Morgan -- Hold 33.00
2026-10-08 RBC Capital -- Buy 56.00
2026-10-02 UBS -- Hold 24.00
2026-09-30 H.C. Wainwright -- Buy 65.00
2026-09-28 H.C. Wainwright -- Buy 65.00
2026-09-11 Barclays -- Buy 74.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-08-12 Oppenheimer Buy → Hold 40.00
2026-07-24 UBS Buy → Hold 28.00
2026-07-13 J.P. Morgan Buy → Hold 35.00
2026-01-22 TD Cowen Buy → Hold 21.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-10 -- ±13.80% -15.97% (beat)
2026/Q2 2026-08-11 -- ±8.77% +5.66% (in line)
2026/Q1 2026-05-12 -- ±9.03% +10.48% (beat)
2025/Q4 2026-03-10 -- ±8.97% +2.19% (in line)
2025/Q3 2025-11-12 -- ±8.98% -2.67% (in line)
2025/Q2 2025-08-11 -- ±10.07% -2.05% (in line)
2025/Q1 2025-05-13 -- ±10.87% -4.01% (in line)
2024/Q3 2024-11-12 -- ±8.20% +0.35% (in line)
2024/Q2 2024-08-09 -- ±14.01% -1.77% (in line)
2024/Q1 2024-05-13 -- ±11.01% -0.62% (in line)
2023/Q4 2024-03-11 -- ±11.96% +3.07% (in line)
2023/Q3 2023-11-20 -- ±11.65% -6.29% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:40 · For reference only, not investment advice and not tailored to your situation.

Legend Biotech discussion 0 comments

Add a comment